SMS Pharmaceuticals Limited has initiated the Investor Education and Protection Fund Authority's (IEPFA) "Second 100 Days Campaign- Saksham Niveshak" as part of its compliance and investor protection efforts. The campaign, which runs from April 1, 2026, to July 9, 2026, aims to reach out to shareholders who have not claimed their dividends or need to update their Know Your Customer (KYC) details.

The company has published newspaper advertisements in The Financial Express (English) and Nava Telangana (Telugu) to inform shareholders about this initiative. The campaign specifically targets shareholders with issues related to unclaimed dividends and shares, encouraging them to take necessary action to prevent their dividends and shares from being transferred to the IEPFA.

Campaign Objectives and Shareholder Action

The primary objective of the Saksham Niveshak campaign is to assist shareholders in updating their essential details and claiming their rightful dues. Shareholders are requested to update the following information:

• KYC requirements
• Bank mandates
• Nominee details
• Contact information

Shareholders who hold shares in demat form are advised to approach their Depository Participants where they maintain their demat accounts for updating their KYC requirements. Those with physical share holdings or other queries can contact the company's Registrar and Transfer Agent.

Contact Information for Shareholders

Shareholders requiring assistance or wishing to claim unclaimed dividends and update their details can reach out to the designated authorities:

The information regarding the campaign has been uploaded on SMS Pharmaceuticals Limited 's website at www.smspharma.com , ensuring easy access for all stakeholders.

Company Details

SMS Pharmaceuticals Limited, with its registered and corporate office located at Plot No. 72, H. No. 8-2-334/3 & 4, Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, operates under the Corporate Identity Number L24239TG1987PLC008066. The company's shares are listed on BSE Limited with the security code 532815 and trading symbol SMSPHARMA.

Thirumalesh Tumma, Company Secretary & Compliance Officer of SMS Pharmaceuticals Limited, issued the notice on behalf of the Board of Directors, emphasizing the company's commitment to investor education and protection.

SMS Pharmaceuticals Limited has informed the stock exchanges that it has received a rectification order under Section 154 of the Income Tax Act, 1961, which substantially reduces the tax demand for Assessment Year 2018-19. The order, issued by the Assistant Commissioner of Income Tax, Hyderabad, on 28th April 2026, has brought down the tax demand from Rs.7.19 crores to Rs.40.28 lakhs.

This development follows the company's earlier intimation dated 31st March 2026 regarding the receipt of a Demand Notice under Section 156 of the Income Tax Act, 1961, which had raised a demand of Rs.7.19 crores for the Assessment Year 2018-19. The original demand was based on an assessment order passed by the Assessment Unit under Section 147 read with Section 144B of the Income Tax Act, involving additions to income and disallowance of deductions under Section 35 of the Act. Additionally, penalty proceedings under Section 270A had been initiated separately for alleged under-reporting of income.

Key Details of the Rectification Order

The company has stated that it has filed an appeal before the Commissioner of Income Tax (Appeals) and also submitted an application for keeping penalty proceedings in abeyance until the disposal of appeals. The company is currently reviewing the rectification order and reevaluating the further steps to be taken against the said order.

Impact Assessment

According to the disclosure, there will not be any material impact at this stage on the financial, operational, and other activities of the company. The communication was made in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, and the Industry Standards note issued vide SEBI Circular No. SEBI/HO/CFD/CFDPoD-2/P/CIR/2025/25 dated February 25, 2025.

The company confirmed that the information provided is true, correct, and complete to the best of its knowledge and belief. The rectification application was filed before the Income Tax Department seeking revision of the tax demand, which has now resulted in a significant reduction in the liability.